Tele: 561.316.3330
Breaking Medical Device News

Thursday, October 21, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeOptim LLCOptim LLC Releases Next Generation LED for ENTity™ Series Flexible Endoscopes

Optim LLC Releases Next Generation LED for ENTity™ Series Flexible Endoscopes

ENTity Laryngoscope Medical Device News Magazine
ENTity Laryngoscope Medical Device News Magazine

Optim LLC, a premier manufacturer of proprietary flexible endoscopes for use in the visual diagnosis of Ear-Nose-and-Throat (“ENT”) disorders, announced today it has released a new, next generation LED-based illumination system in its ENTity line of flexible laryngoscopes.

On Key Enhancements:  Paul Joyce, President and CEO of Optim, “We are happy to announce this key enhancement to our ENTity series of products. ” Joyce added, “Our innovative flexible laryngoscopes for the ENT provider not only offers the best in health care portability and ease of use, but now includes a brighter, truer white-light color temperature we believe enhances the visual experience for diagnostics.”

The ENTity XL and SDXL models now feature a maximum brightness 15%-18% higher than the previous generation. Additionally, the new generation LED system in the endoscopes provide a vibrant white light targeted in the 5500K color temperature range for superior tissue color differentiation.

The ENTity Series of flexible laryngoscopes are utilized daily to diagnose and manage airway, voice, and swallowing disorders. The ENTity Series features the company’s patented OptiLux™ self-contained LED illumination system, providing practitioners with a high-quality, easy-to-use imaging device that can be employed in nearly any health care setting without ancillary equipment common to other endoscopy systems.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Contraline Closes $10.7 Million Series A Financing to Become a Clinical Stage Company

This infusion of capital will support the initiation of a first-in-human trial of ADAM™, the world’s first hydrogel implant designed to provide long-lasting, non-permanent contraception for men.

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Luciana Borio MD is a respected physician with vast experience in advancing major regulatory and policy agendas for the United States.

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

By using this website you agree to accept Medical Device News Magazine Privacy Policy